Lisa Marr

1.7k total citations
32 papers, 1.2k citations indexed

About

Lisa Marr is a scholar working on Public Health, Environmental and Occupational Health, General Health Professions and Epidemiology. According to data from OpenAlex, Lisa Marr has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 5 papers in General Health Professions and 5 papers in Epidemiology. Recurrent topics in Lisa Marr's work include Palliative Care and End-of-Life Issues (14 papers), Patient Dignity and Privacy (8 papers) and Pain Management and Opioid Use (3 papers). Lisa Marr is often cited by papers focused on Palliative Care and End-of-Life Issues (14 papers), Patient Dignity and Privacy (8 papers) and Pain Management and Opioid Use (3 papers). Lisa Marr collaborates with scholars based in United States, Germany and United Kingdom. Lisa Marr's co-authors include Rae Lyn Burke, Allen Izu, Cornelia L. Dekker, Stephen K. Tyring, Holly Yang, Richard P. DiCarlo, Andria Langenberg, Wendy G. Anderson, Robert M. Arnold and John M. Douglas and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Lisa Marr

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Marr United States 15 477 457 285 147 125 32 1.2k
Nahida Chakhtoura United States 21 404 0.8× 565 1.2× 153 0.5× 166 1.1× 66 0.5× 67 1.4k
Rosemary G. McKaig United States 18 1.4k 2.9× 677 1.5× 219 0.8× 135 0.9× 106 0.8× 21 3.0k
Patricia Barlow Belgium 20 628 1.3× 329 0.7× 90 0.3× 120 0.8× 52 0.4× 50 1.4k
Alison C. Roxby United States 14 100 0.2× 273 0.6× 217 0.8× 47 0.3× 109 0.9× 53 793
Sonja S. Hutchins United States 21 124 0.3× 661 1.4× 176 0.6× 170 1.2× 35 0.3× 39 1.2k
Natasha Larke United Kingdom 19 287 0.6× 545 1.2× 131 0.5× 92 0.6× 65 0.5× 33 1.6k
Lisa M. Hollier United States 26 388 0.8× 570 1.2× 130 0.5× 67 0.5× 194 1.6× 78 1.9k
Meritxell Sabidó Spain 18 106 0.2× 303 0.7× 162 0.6× 85 0.6× 93 0.7× 62 788
Maria Fenicia Vescio Italy 21 309 0.6× 420 0.9× 89 0.3× 41 0.3× 68 0.5× 63 1.4k
Ameeta E. Singh Canada 23 279 0.6× 723 1.6× 195 0.7× 60 0.4× 908 7.3× 104 1.9k

Countries citing papers authored by Lisa Marr

Since Specialization
Citations

This map shows the geographic impact of Lisa Marr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Marr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Marr more than expected).

Fields of papers citing papers by Lisa Marr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Marr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Marr. The network helps show where Lisa Marr may publish in the future.

Co-authorship network of co-authors of Lisa Marr

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Marr. A scholar is included among the top collaborators of Lisa Marr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Marr. Lisa Marr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langenmayer, Martin C., Lisa Marr, Sylvia Jany, et al.. (2023). Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice. Pathogens. 12(7). 867–867. 6 indexed citations
2.
Marr, Lisa, Bernhard Haller, Jan C. Peeken, et al.. (2022). Predictive value of clinical and 18F-FDG-PET/CT derived imaging parameters in patients undergoing neoadjuvant chemoradiation for esophageal squamous cell carcinoma. Scientific Reports. 12(1). 7148–7148. 4 indexed citations
3.
George, Naomi, Nicole Lee, Lisa Marr, et al.. (2021). It Takes a Region: Rural-Academic Partnerships to Decrease Health Inequity During the Pandemic. Journal of Pain and Symptom Management. 61(5). e4–e6. 1 indexed citations
4.
Münch, Stefan, Lisa Marr, Benedikt Feuerecker, et al.. (2020). Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients. Strahlentherapie und Onkologie. 196(9). 787–794. 5 indexed citations
5.
Arora, Sanjeev, et al.. (2017). Project ECHO: an effective means of increasing palliative care capacity.. PubMed. 23(7 Spec No.). SP267–SP271. 24 indexed citations
6.
7.
Morley, Sarah, Emily A. Haozous, Esmé Finlay, et al.. (2016). Palliative Care for American Indians and Alaska Natives: A Review of the Literature. Journal of Palliative Medicine. 19(12). 1331–1340. 17 indexed citations
8.
Volz, Asisa, Stephanie M. Lim, Lisa Marr, et al.. (2016). Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens. Vaccine. 34(16). 1915–1926. 19 indexed citations
9.
Marr, Lisa, et al.. (2016). Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes. Virology. 499. 322–330. 7 indexed citations
10.
Marr, Lisa, et al.. (2015). Utilization of palliative care consultation service by surgical services.. PubMed. 4(4). 194–9. 46 indexed citations
11.
Eneanya, Nwamaka D., Sarah L. Goff, John L. Griffith, et al.. (2015). Shared decision-making in end-stage renal disease: a protocol for a multi-center study of a communication intervention to improve end-of-life care for dialysis patients. BMC Palliative Care. 14(1). 30–30. 34 indexed citations
12.
Goff, Sarah L., Nwamaka D. Eneanya, Michael J. Germain, et al.. (2015). Advance Care Planning. Clinical Journal of the American Society of Nephrology. 10(3). 390–400. 81 indexed citations
13.
Marr, Lisa, et al.. (2014). Utilization of Palliative Care Consultation Service by Surgical Services at University of New Mexico. Journal of the American College of Surgeons. 219(3). S54–S54. 1 indexed citations
14.
Katzman, Joanna G., George D. Comerci, Michael Landen, et al.. (2014). Rules and Values: A Coordinated Regulatory and Educational Approach to the Public Health Crises of Chronic Pain and Addiction. American Journal of Public Health. 104(8). 1356–1362. 32 indexed citations
15.
Prigerson, Holly G., Elizabeth Paulk, Jennifer S. Temel, et al.. (2013). Gender differences in the evolution of illness understanding among patients with advanced cancer. PubMed. 11(3). 126–132. 42 indexed citations
16.
Pound, John D., Lisa Marr, С. А. Петрова, et al.. (2013). Innate recognition of apoptotic cells: novel apoptotic cell-associated molecular patterns revealed by crossreactivity of anti-LPS antibodies. Cell Death and Differentiation. 20(5). 698–708. 13 indexed citations
17.
Balboni, Tracy A., Paul K. Maciejewski, Michael J. Balboni, et al.. (2013). Racial/ethnic differences in end-of-life (EoL) treatment preferences: The role of religious beliefs about care.. Journal of Clinical Oncology. 31(15_suppl). 6529–6529. 2 indexed citations
18.
Marr, Lisa, et al.. (2012). Confronting Myths: The Native American Experience in an Academic Inpatient Palliative Care Consultation Program. Journal of Palliative Medicine. 15(1). 71–76. 28 indexed citations
19.
Back, Anthony L., Wendy G. Anderson, Lisa Marr, et al.. (2008). Communication about cancer near the end of life. Cancer. 113(S7). 1897–1910. 144 indexed citations
20.
Corey, Lawrence, Andria Langenberg, Rhoda L. Ashley, et al.. (1999). Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection. JAMA. 282(4). 331–40. 370 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026